Clinical Trial Update: ESI With EUS to Differentiate T3 and T4 ESCC [Phase 1]

View source ↗

Summary

A Phase 1 trial update evaluating endoscopic submucosal injection with endoscopic ultrasound to differentiate T3 vs T4 esophageal squamous cell carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Snippet

Sponsor: Sun Yat-sen University | Conditions: Esophageal Cancer | Phase 1 | Status: UNKNOWN